{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T06:37:31Z","timestamp":1792132651484,"version":"4.4.0"},"reference-count":81,"publisher":"Bentham Science Publishers Ltd.","issue":"20","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["MRMC"],"published-print":{"date-parts":[[2024,11]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>The oxidative deamination of a wide range of endogenous and exogenous\namines is catalyzed by a family of enzymes known as monoamine oxidases (MAOs), which are reliant\non flavin-adenine dinucleotides. Numerous neurological conditions, such as Parkinson's disease\n(PD) and Alzheimer's disease (AD), are significantly correlated with changes in the amounts of biogenic\namines in the brain caused by MAO. Hydrogen peroxide, reactive oxygen species, and ammonia,\namong other toxic consequences of this oxidative breakdown, can harm brain cells' mitochondria\nand cause oxidative damage.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p>The prime objective of this review article was to highlight and conclude the recent advancements\nin structure-activity relationships of synthetic derivatives of coumarins for MAO-B inhibition,\npublished in the last five years' research articles.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>The literature (between 2019 and 2023) was searched from platforms like Science Direct,\nGoogle Scholar, PubMed, etc. After going through the literature, we have found a number of coumarin\nderivatives being synthesized by researchers for the inhibition of MAO-B for the management\nof diseases associated with the enzyme such as Alzheimer\u2019s Disease and Parkinson\u2019s Disease. The\neffect of these coumarin derivatives on the enzyme depends on the substitutions associated with the\nstructure. The structure-activity relationships of the synthetic coumarin derivatives that are popular\nnowadays have been described and summarized in the current study.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>The results revealed the updated review on SAR studies of synthetic coumarins as MAO-B\ninhibitors, specifically for Alzheimer\u2019s Disease and Parkinson\u2019s Disease. The patents reported on\ncoumarin derivatives as MAO-B inhibitors were also highlighted.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>Recently, coumarins, a large class of chemicals with both natural and synthetic\nsources, have drawn a lot of attention because of the vast range of biological actions they have that\nare linked to neurological problems. Numerous studies have demonstrated that chemically produced\nand naturally occurring coumarin analogs both exhibited strong MAO-B inhibitory action. Coumarins\nbind to MAO-B reversibly thereby preventing the breakdown of neurotransmitters like dopamine\nleading to the inhibition of the enzyme A number of MAO-B blockers have been proven to be\nefficient therapies for treating neurological diseases like Alzheimer\u2019s Disease and Parkinson\u2019s Disease.\nTo combat these illnesses, there is still an urgent need to find effective treatment compounds.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0113895575290599240503080025","type":"journal-article","created":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T07:28:55Z","timestamp":1716449335000},"page":"1834-1846","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Recent Advancements and SAR Studies of Synthetic Coumarins as MAO-B Inhibitors: An Updated Review"],"prefix":"10.2174","volume":"24","author":[{"given":"Prabhjot","family":"Kaur","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Chemistry, ISF College of Pharmacy, Moga, Punjab, 142001, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6118-4710","authenticated-orcid":true,"given":"Naresh Kumar","family":"Rangra","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, ISF College of Pharmacy, Moga, Punjab, 142001, India"},{"name":"Chitkara School\nof Pharmacy, Chitkara University, Baddi, Himachal Pradesh, 174103, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2021\/8879014","volume":"2021","author":"Liu L.","year":"2021","unstructured":"Liu L.; Zhang Y.; Tang L.; Zhong H.; Danzeng D.; Liang C.; Liu S.; The neuroprotective effect of Byu d Mar 25 in LPS-induced alzheimer\u2019s disease mice model. Evid Based Complement Alternat Med  2021,2021,1-12","journal-title":"Evid Based Complement Alternat Med"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"e35391","DOI":"10.1097\/MD.0000000000035391","volume":"102","author":"Zeng W.","year":"2023","unstructured":"Zeng W.; Yu L.; Wu J.; Wang F.; Liu X.; Ren S.; Zhang D.; Lian B.; Hu M.; Cao L.; Clinical characteristics and long-term follow-up outcomes of myelin oligodendrocyte glycoprotein antibody-associated disease in Han Chinese participants. Medicine  2023,102(40),e35391","journal-title":"Medicine"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1007\/s11655-023-3598-z","volume":"29","author":"Yi J.","year":"2023","unstructured":"Yi J.; Li L.; Yin Z.; Quan Y.; Tan R.; Chen S.; Lang J.; Li J.; Zeng J.; Li Y.; Sun Z.; Zhao J.; Polypeptide from moschus suppresses lipopolysaccharide-induced inflammation by inhibiting NF-\u03ba B-ROS\/NLRP3 pathway. Chin J Integr Med  2023,29(10),895-904","journal-title":"Chin J Integr Med"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1038\/s12276-021-00646-3","volume":"53","author":"Cho H.U.","year":"2021","unstructured":"Cho H.U.; Kim S.; Sim J.; Yang S.; An H.; Nam M.H.; Jang D.P.; Lee C.J.; Redefining differential roles of MAO-A in dopamine degradation and MAO-B in tonic GABA synthesis. Exp Mol Med  2021,53(7),1148-1158","journal-title":"Exp Mol Med"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1186\/s12967-023-04137-z","volume":"21","author":"Liu Y.","year":"2023","unstructured":"Liu Y.; Li H.; Wang X.; Huang J.; Zhao D.; Tan Y.; Zhang Z.; Zhang Z.; Zhu L.; Wu B.; Chen Z.; Peng W.; Anti-alzheimers molecular mechanism of icariin: Insights from gut microbiota, metabolomics, and network pharmacology. J Transl Med  2023,21(1),277-0","journal-title":"J Transl Med"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"2434","DOI":"10.1016\/j.bmc.2013.02.017","volume":"21","author":"Patil P.O.","year":"2013","unstructured":"Patil P.O.; Bari S.B.; Firke S.D.; Deshmukh P.K.; Donda S.T.; Patil D.A.; A comprehensive review on synthesis and designing aspects of coumarin derivatives as monoamine oxidase inhibitors for depression and Alzheimer\u2019s disease. Bioorg Med Chem  2013,21(9),2434-2450","journal-title":"Bioorg Med Chem"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"3724","DOI":"10.3390\/molecules26123724","volume":"26","author":"Behl T.","year":"2021","unstructured":"Behl T.; Kaur D.; Sehgal A.; Singh S.; Sharma N.; Zengin G.; Cioara A.F.L.; Toma M.M.; Bungau S.; Bumbu A.G.; Role of monoamine oxidase activity in Alzheimer\u2019s disease: an insight into the therapeutic potential of inhibitors. Molecules  2021,26(12),3724","journal-title":"Molecules"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.abb.2007.05.006","volume":"464","author":"Edmondson D.E.","year":"2007","unstructured":"Edmondson D.E.; Binda C.; Mattevi A.; Structural insights into the mechanism of amine oxidation by monoamine oxidases A and B. Arch Biochem Biophys  2007,464(2),269-276","journal-title":"Arch Biochem Biophys"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1007\/s00702-023-02623-8","volume":"130","author":"Regensburger M.","year":"2023","unstructured":"Regensburger M.; Ip C.W.; Kohl Z.; Schrader C.; Urban P.P.; Kassubek J.; Jost W.H.; Clinical benefit of MAO-B and COMT inhibition in Parkinson\u2019s disease: Practical considerations. J Neural Transm  2023,130(6),847-861","journal-title":"J Neural Transm"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"0017","DOI":"10.34133\/cbsystems.0017","volume":"4","author":"Liu H","year":"2023","unstructured":"Liu H; Li B; Xi P; Liu Y; Li F; Lang Y; Tang R; Ma N; He J; Time-varying functional connectivity of rat brain during bipedal walking on unexpected terrain. Cyborg and Bionic Systems  2023,4,0017","journal-title":"Cyborg and Bionic Systems"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"e12884","DOI":"10.1097\/MD.0000000000012884","volume":"97","author":"Li J.","year":"2018","unstructured":"Li J.; Luo J.; Liu L.; Fu H.; Tang L.; The genetic association between apolipoprotein E gene polymorphism and Parkinson disease. Medicine  2018,97(43),e12884-e0","journal-title":"Medicine"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"0034","DOI":"10.34133\/cbsystems.0034","volume":"4","author":"Yeh CH","year":"2023","unstructured":"Yeh CH; Zhang C; Shi W; Lo MT; Tinkhauser G; Oswal A; Cross-frequency coupling and intelligent neuromodulation. Cyborg Bion Syst  2023,4,0034","journal-title":"Cyborg Bion Syst"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/07391102.2023.2260879","volume":"29","author":"Boulaamane Y.","year":"2023","unstructured":"Boulaamane Y.; Kandpal P.; Chandra A.; Britel M.R.; Maurady A.; Chemical library design, QSAR modeling and molecular dynamics simulations of naturally occurring coumarins as dual inhibitors of MAO-B and AChE. J Biomol Struct Dyn  2023,29,1-8","journal-title":"J Biomol Struct Dyn"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"1002547","DOI":"10.3389\/fchem.2022.1002547","volume":"10","author":"Pisani L.","year":"2022","unstructured":"Pisani L.; Catto M.; Muncipinto G.; Nicolotti O.; Carrieri A.; Rullo M.; Stefanachi A.; Leonetti F.; Altomare C.; A twenty-year journey exploring coumarin-based derivatives as bioactive molecules. Front Chem  2022,10,1002547","journal-title":"Front Chem"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"103964","DOI":"10.1016\/j.bioorg.2020.103964","volume":"101","author":"Mellado M.","year":"2020","unstructured":"Mellado M.; Mella J.; Gonz\u00e1lez C.; Vi\u00f1a D.; Uriarte E.; Matos M.J.; 3-Arylcoumarins as highly potent and selective monoamine oxidase B inhibitors: Which chemical features matter? Bioorg Chem  2020,101,103964","journal-title":"Bioorg Chem"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1016\/j.jff.2013.05.011","volume":"5","author":"Seo W.D.","year":"2013","unstructured":"Seo W.D.; Kim J.Y.; Ryu H.W.; Kim J.H.; Han S.I.; Ra J.E.; Seo K.H.; Jang K.C.; Lee J.H.; Identification and characterisation of coumarins from the roots of Angelica dahurica and their inhibitory effects against cholinesterase. J Funct Foods  2013,5(3),1421-1431","journal-title":"J Funct Foods"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"217","DOI":"10.3109\/13880200903019226","volume":"48","author":"Iranshahi M.","year":"2010","unstructured":"Iranshahi M.; Kalategi F.; Sahebkar A.; Sardashti A.; Schneider B.; New sesquiterpene coumarins from the roots of Ferula flabelliloba. Pharm Biol  2010,48(2),217-220","journal-title":"Pharm Biol"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1080\/10286020.2012.758635","volume":"15","author":"Peng W.W.","year":"2013","unstructured":"Peng W.W.; Zheng Y.Q.; Chen Y.S.; Zhao S.M.; Ji C.J.; Tan N.H.; Coumarins from roots of Clausena excavata. J Asian Nat Prod Res  2013,15(3),215-220","journal-title":"J Asian Nat Prod Res"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.14233\/ajchem.2013.13208","volume":"25","author":"Naseri M.","year":"2013","unstructured":"Naseri M.; Monsef-Esfehani H.R.; Saeidnia S.; Dastan D.; Gohari A.R.; Antioxidative coumarins from the roots of ferulago subvelutina. Asian J Chem  2013,25(4),1875-1878","journal-title":"Asian J Chem"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.jff.2015.11.018","volume":"20","author":"Bai Y.","year":"2016","unstructured":"Bai Y.; Li D.; Zhou T.; Qin N.; Li Z.; Yu Z.; Hua H.; Coumarins from the roots of Angelica dahurica with antioxidant and antiproliferative activities. J Funct Foods  2016,20,453-462","journal-title":"J Funct Foods"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"1934578X1300800","DOI":"10.1177\/1934578X1300800508","volume":"8","author":"Joshi K.R.","year":"2013","unstructured":"Joshi K.R.; Devkota H.P.; Yahara S.; Chemical analysis of flowers of Bombax ceiba from Nepal. Nat Prod Commun  2013,8(5),1934578X1300800","journal-title":"Nat Prod Commun"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/S1995-7645(11)60183-1","volume":"4","author":"Sukumaran S.","year":"2011","unstructured":"Sukumaran S.; Kiruba S.; Mahesh M.; Nisha S.R.; Miller P.Z.; Ben C.P.; Jeeva S.; Phytochemical constituents and antibacterial efficacy of the flowers of peltophorum pterocarpum (DC.) baker ex heyne. Asian Pac J Trop Med  2011,4(9),735-738","journal-title":"Asian Pac J Trop Med"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1007\/s10600-012-0179-3","volume":"48","author":"Kicel A.","year":"2012","unstructured":"Kicel A.; Wolbis M.; Coumarins from the flowers of Trifolium repens. Chem Nat Compd  2012,48(1),130-132","journal-title":"Chem Nat Compd"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"4","DOI":"10.2174\/1385272824666200120144305","volume":"24","author":"Molnar M.","year":"2020","unstructured":"Molnar M.; Lon\u010dari\u0107 M.; Kova\u010d M.; Green chemistry approaches to the synthesis of coumarin derivatives. Curr Org Chem  2020,24(1),4-43","journal-title":"Curr Org Chem"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"e202104299","DOI":"10.1002\/slct.202104299","volume":"7","author":"Sharma D.","year":"2022","unstructured":"Sharma D.; Dhayalan V.; Chatterjee R.; Khatravath M.; Dandela R.; Recent advances in the synthesis of coumarin and its derivatives by using aryl propiolates. ChemistrySelect  2022,7(4),e202104299","journal-title":"ChemistrySelect"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"2756","DOI":"10.1080\/00397911.2014.926374","volume":"44","author":"Vekariya R.H.","year":"2014","unstructured":"Vekariya R.H.; Patel H.D.; Recent advances in the synthesis of coumarin derivatives via Knoevenagel condensation: A review. Synth Commun  2014,44(19),2756-2788","journal-title":"Synth Commun"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1080\/00397911.2013.862833","volume":"44","author":"He X.","year":"2014","unstructured":"He X.; Yan Z.; Hu X.; Zuo Y.; Jiang C.; Jin L.; Shang Y.; FeCl 3 -catalyzed cascade reaction: An efficient approach to functionalized coumarin derivatives. Synth Commun  2014,44(10),1507-1514","journal-title":"Synth Commun"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"175958","DOI":"10.1016\/j.ejphar.2023.175958","volume":"956","author":"Akwu N.A.","year":"2023","unstructured":"Akwu N.A.; Lekhooa M.; Deqiang D.; Aremu A.O.; Antidepressant effects of coumarins and their derivatives: A critical analysis of research advances. Eur J Pharmacol  2023,956,175958","journal-title":"Eur J Pharmacol"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"104203","DOI":"10.1016\/j.bioorg.2020.104203","volume":"104","author":"Enr\u00edquez R.F.","year":"2020","unstructured":"Enr\u00edquez R.F.; Lago C.M.C.; Besada P.; Pena A.M.; Ter\u00e1n T.I.; Vi\u00f1a D.; Fontenla J.\u00c1.; Sturlese M.; Moro S.; Quezada E.; Ter\u00e1n C.; Novel coumarin-pyridazine hybrids as selective MAO-B inhibitors for the Parkinson\u2019s disease therapy. Bioorg Chem  2020,104,104203","journal-title":"Bioorg Chem"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"6492346","DOI":"10.1155\/2021\/6492346","volume":"2021","author":"Rad S.J.","year":"2021","unstructured":"Rad S.J.; Martins C.N.; Jornet L.P.; Lopez E.P.; Harun N.; Yeskaliyeva B.; Beyatli A.; Sytar O.; Shaheen S.; Sharopov F.; Taheri, Y Natural coumarins: Exploring the pharmacological complexity and underlying molecular mechanisms. Oxid Med Cell Longev  2021,2021,6492346","journal-title":"Oxid Med Cell Longev"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"592853","DOI":"10.3389\/fonc.2020.592853","volume":"10","author":"Wu Y.","year":"2020","unstructured":"Wu Y.; Xu J.; Liu Y.; Zeng Y.; Wu G.; A review on anti-tumor mechanisms of coumarins. Front Oncol  2020,10,592853","journal-title":"Front Oncol"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1111\/jcpt.13343","volume":"46","author":"Wadsworth D.","year":"2021","unstructured":"Wadsworth D.; Sullivan E.; Jacky T.; Sprague T.; Feinman H.; Kim J.; A review of indications and comorbidities in which warfarin may be the preferred oral anticoagulant. J Clin Pharm Ther  2021,46(3),560-570","journal-title":"J Clin Pharm Ther"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1080\/10426500008043675","volume":"160","author":"El-Saghier A.M.M.","year":"2000","unstructured":"El-Saghier A.M.M.; Khodairy A.; New synthetic approaches to condensed and spiro coumarins: coumarin-3-thiocarboxamide as building block for the synthesis of condensed and spiro coumarins. Phosphorus Sulfur Silicon Relat Elem  2000,160(1),105-119","journal-title":"Phosphorus Sulfur Silicon Relat Elem"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"4559","DOI":"10.5958\/0974-360X.2019.00784.4","volume":"12","author":"Khokhlenkova N.V.","year":"2019","unstructured":"Khokhlenkova N.V.; Buryak M.V.; Povrozina O.V.; Kamina T.V.; Principles of the urolithiasis phytotherapy. Res J Pharm Technol  2019,12(9),4559-4564","journal-title":"Res J Pharm Technol"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1152\/physrev.00022.2019","volume":"100","author":"Michel J.B.","year":"2020","unstructured":"Michel J.B.; Phylogenic determinants of cardiovascular frailty, focus on hemodynamics and arterial smooth muscle cells. Physiol Rev  2020,100(4),1779-1837","journal-title":"Physiol Rev"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"135336","DOI":"10.1016\/j.molstruc.2023.135336","volume":"1283","author":"Dabhi R.C.","year":"2023","unstructured":"Dabhi R.C.; Sharma V.S.; Arya P.S.; Patel U.P.; Shrivastav P.S.; Maru J.J.; Coumarin functionalized dimeric mesogens for promising anticoagulant activity: Tuning of liquid crystalline property. J Mol Struct  2023,1283,135336","journal-title":"J Mol Struct"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"120922","DOI":"10.1016\/j.lfs.2022.120922","volume":"308","author":"Siddiqi A.","year":"2022","unstructured":"Siddiqi A.; Rani M.; Bansal P.; Rizvi M.M.A.; Renal cell carcinoma management: A step to nano-chemoprevention. Life Sci  2022,308,120922-0","journal-title":"Life Sci"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"102050","DOI":"10.1016\/j.tube.2020.102050","volume":"127","author":"Reddy D.S.","year":"2021","unstructured":"Reddy D.S.; Kongot M.; Kumar A.; Coumarin hybrid derivatives as promising leads to treat tuberculosis: Recent developments and critical aspects of structural design to exhibit anti-tubercular activity. Tuberculosis  2021,127,102050-0","journal-title":"Tuberculosis"},{"key":"ref=39","first-page":"9820","volume":"31","author":"Singh A.","year":"2022","unstructured":"Singh A.; Yagnik S.K.; Tripathi N.; Khatoon Y.; Pandey M.; Verma P.; Design and synthesis of 3-arylcoumerin derivatives as a selective mao-B inhibitor. J Pharm Negat Results  2022,31,9820-9833","journal-title":"J Pharm Negat Results"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"104685","DOI":"10.1016\/j.bioorg.2021.104685","volume":"109","author":"Liu L.","year":"2021","unstructured":"Liu L.; Chen Y.; Zeng R.F.; Liu Y.; Xie S.S.; Lan J.S.; Ding Y.; Yang Y.T.; Yang J.; Zhang T.; Design and synthesis of novel 3,4-dihydrocoumarins as potent and selective monoamine oxidase-B inhibitors with the neuroprotection against Parkinson\u2019s disease. Bioorg Chem  2021,109,104685-0","journal-title":"Bioorg Chem"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3389\/fendo.2019.00012","volume":"10","author":"Li F.","year":"2019","unstructured":"Li F.; Li D.; Liu H.; Cao B.B.; Jiang F.; Chen D.N.; Li J.D.; RNF216 regulates the migration of immortalized GnRH neurons by suppressing Beclin1-mediated autophagy. Front Endocrinol  2019,10,12","journal-title":"Front Endocrinol"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.3892\/or.2017.5469","volume":"37","author":"Shen F.","year":"2017","unstructured":"Shen F.; Long D.; Yu T.; Chen X.; Liao Y.; Wu Y.; Lin X.; Vinblastine differs from Taxol as it inhibits the malignant phenotypes of NSCLC cells by increasing the phosphorylation of Op18\/stathmin. Oncol Rep  2017,37(4),2481-2489","journal-title":"Oncol Rep"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1111\/all.15111","volume":"77","author":"Zhou Y.","year":"2022","unstructured":"Zhou Y.; Li Q.; Pan R.; Wang Q.; Zhu X.; Yuan C.; Cai F.; Gao Y.; Cui Y.; Regulatory roles of three miRNAs on allergen mRNA expression in Tyrophagus putrescentiae. Allergy  2022,77(2),469-482","journal-title":"Allergy"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1002\/cmdc.202000454","volume":"16","author":"Enr\u00edquez R.F.","year":"2021","unstructured":"Enr\u00edquez R.F.; Vi\u00f1a D.; Uriarte E.; Laguna R.; Matos M.J.; 7\u2010Amidocoumarins as multitarget agents against neurodegenerative diseases: Substitution pattern modulation. ChemMedChem  2021,16(1),179-186","journal-title":"ChemMedChem"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"7698","DOI":"10.1002\/slct.201901282","volume":"4","author":"Mellado M.","year":"2019","unstructured":"Mellado M.; Salas C.O.; Uriarte E.; Vi\u00f1a D.; Guti\u00e9rrez J.C.; Matos M.J.; Cuellar M.; Design, synthesis and docking calculations of prenylated chalcones as selective monoamine oxidase B inhibitors with antioxidant activity. ChemistrySelect  2019,4(26),7698-7703","journal-title":"ChemistrySelect"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"3900","DOI":"10.1016\/j.bmc.2013.04.015","volume":"21","author":"Matos M.J.","year":"2013","unstructured":"Matos M.J.; P\u00e9rez-Cruz F.; Vazquez-Rodriguez S.; Uriarte E.; Santana L.; Borges F.; Olea-Azar C.; Remarkable antioxidant properties of a series of hydroxy-3-arylcoumarins. Bioorg Med Chem  [l]2013,21(13),3900-3906","journal-title":"Bioorg Med Chem"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"e22651","DOI":"10.1002\/jbt.22651","volume":"35","author":"Musa M.A.","year":"2021","unstructured":"Musa M.A.; Badisa V.L.D.; Aghimien M.O.; Eyunni S.V.K.; Latinwo L.M.; Identification of 7,8\u2010dihydroxy\u20103\u2010phenylcoumarin as a reversible monoamine oxidase enzyme inhibitor. J Biochem Mol Toxicol  2021,35(2),e22651-e0","journal-title":"J Biochem Mol Toxicol"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s12906-016-1525-y","volume":"17","author":"Zarmouh N.O.","year":"2017","unstructured":"Zarmouh N.O.; Eyunni S.K.; Soliman K.F.A.; The benzopyrone biochanin-A as a reversible, competitive, and selective monoamine oxidase B inhibitor. BMC Complement Altern Med  2017,17(1),34","journal-title":"BMC Complement Altern Med"},{"key":"ref=49","first-page":"6005","volume":"37","author":"Musa M.A.","year":"2017","unstructured":"Musa M.A.; Latinwo L.M.; Joseph M.Y.; Badisa V.L.; Identification of 7,8-diacetoxy-3-arylcoumarin derivative as a selective cytotoxic and apoptosis-inducing agent in a human prostate cancer cell line. Anticancer Res  2017,37(11),6005-6014","journal-title":"Anticancer Res"},{"key":"ref=50","author":"McGann M.","unstructured":"McGann M.; OEDOCKING 3.0.1; OpenEye Scientific Software: Santa Fe, New Mexico, 0000."},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1039\/C6MD00586A","volume":"8","author":"Lan J.S.","year":"2017","unstructured":"Lan J.S.; Zhang T.; Liu Y.; Zhang Y.; Hou J.; Xie S.S.; Yang J.; Ding Y.; Cai Z.; Synthesis and evaluation of small molecules bearing a benzyloxy substituent as novel and potent monoamine oxidase inhibitors. MedChemComm  2017,8(2),471-478","journal-title":"MedChemComm"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3389\/fchem.2018.00041","volume":"6","author":"Rauham\u00e4ki S.","year":"2018","unstructured":"Rauham\u00e4ki S.; Postila P.A.; Niinivehmas S.; Kortet S.; Schildt E.; Pasanen M.; Manivannan E.; Ahinko M.; Koskimies P.; Nyberg N.; Huuskonen P.; Multam\u00e4ki E.; Pasanen M.; Juvonen R.O.; Raunio H.; Huuskonen J.; Pentik\u00e4inen O.T.; Structure-activity relationship analysis of 3-phenylcoumarin-based monoamine oxidase B inhibitors. Front Chem  2018,6,4","journal-title":"Front Chem"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"4003","DOI":"10.3390\/molecules24214003","volume":"24","author":"Wang D.","year":"2019","unstructured":"Wang D.; Hong R.Y.; Guo M.; Liu Y.; Chen N.; Li X.; Kong D.X.; Novel C7-substituted coumarins as selective monoamine oxidase inhibitors: Discovery, synthesis and theoretical simulation. Molecules  2019,24(21),4003-0","journal-title":"Molecules"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"2820","DOI":"10.1021\/ci400432a","volume":"53","author":"Deng Z.L.","year":"2013","unstructured":"Deng Z.L.; Du C.X.; Li X.; Hu B.; Kuang Z.K.; Wang R.; Feng S.Y.; Zhang H.Y.; Kong D.X.; Exploring the biologically relevant chemical space for drug discovery. J Chem Inf Model  2013,53(11),2820-2828","journal-title":"J Chem Inf Model"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.3390\/molecules21111554","volume":"21","author":"Hu B.","year":"2016","unstructured":"Hu B.; Kuang Z.K.; Feng S.Y.; Wang D.; He S.B.; Kong D.X.; Three-dimensional biologically relevant spectrum (BRS-3D): Shape similarity profile based on PDB ligands as molecular descriptors. Molecules  2016,21(11),1554","journal-title":"Molecules"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1006\/jmbi.1996.0897","volume":"267","author":"Jones G.","year":"1997","unstructured":"Jones G.; Willett P.; Glen R.C.; Leach A.R.; Taylor R.; Development and validation of a genetic algorithm for flexible docking. J Mol Biol  1997,267,727-748","journal-title":"J Mol Biol"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"7127","DOI":"10.1021\/jm200716y","volume":"54","author":"Matos M.J.","year":"2011","unstructured":"Matos M.J.; Ter\u00e1n C.; Castillo P.Y.; Uriarte E.; Santana L.; Vi\u00f1a D.; Synthesis and study of a series of 3-arylcoumarins as potent and selective monoamine oxidase B inhibitors. J Med Chem  2011,54(20),7127-7137","journal-title":"J Med Chem"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1159\/000357281","volume":"13","author":"Y\u00e1\u00f1ez M.","year":"2014","unstructured":"Y\u00e1\u00f1ez M.; Mat\u00edas-Guiu J.; Arranz-Tagarro J.A.; Gal\u00e1n L.; Vi\u00f1a D.; G\u00f3mez-Pinedo U.; Vela \u00c1.; Guerrero A.; Vila M.E.; Garc\u00eda A.G.; The neuroprotection exerted by memantine, minocycline and lithium, against neurotoxicity of CSF from patients with amyotrophic lateral sclerosis, is antagonized by riluzole. Neurodegener Dis  2014,13(2-3),171-179","journal-title":"Neurodegener Dis"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"11235","DOI":"10.1021\/acs.joc.6b02207","volume":"81","author":"Schmidt B.","year":"2016","unstructured":"Schmidt B.; Wolf F.; Ehlert C.; Systematic investigation into the matsuda\u2013heck reaction of \u03b1-methylene lactones: How conformational constraints direct the \u03b2-h-elimination step. J Org Chem  2016,81(22),11235-11249","journal-title":"J Org Chem"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1039\/C5MD00124B","volume":"6","author":"Lan J.S.","year":"2015","unstructured":"Lan J.S.; Xie S.S.; Huang M.; Hu Y.J.; Kong L.Y.; Wang X.B.; Chromanones: Selective and reversible monoamine oxidase B inhibitors with nanomolar potency. MedChemComm  2015,6(7),1293-1302","journal-title":"MedChemComm"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.ejmech.2015.03.040","volume":"95","author":"Xie S.S.","year":"2015","unstructured":"Xie S.S.; Wang X.; Jiang N.; Yu W.; Wang K.D.G.; Lan J.S.; Li Z.R.; Kong L.Y.; Multi-target tacrine-coumarin hybrids: Cholinesterase and monoamine oxidase B inhibition properties against Alzheimer\u2019s disease. Eur J Med Chem  2015,95,153-165","journal-title":"Eur J Med Chem"},{"key":"ref=62","unstructured":"Molinspiration chemoinformatics.  Available from:\n http:\/\/www.molinspiration.com\/services\/properties.html"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/j.ejmech.2011.01.033","volume":"46","author":"Delogu G.","year":"2011","unstructured":"Delogu G.; Picciau C.; Ferino G.; Quezada E.; Podda G.; Uriarte E.; Vi\u00f1a D.; Synthesis, human monoamine oxidase inhibitory activity and molecular docking studies of 3-heteroarylcoumarin derivatives. Eur J Med Chem  2011,46(4),1147-1152","journal-title":"Eur J Med Chem"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejmech.2017.07.045","volume":"139","author":"Costas-Lago M.C.","year":"2017","unstructured":"Costas-Lago M.C.; Besada P.; Rodr\u00edguez-Enr\u00edquez F.; Vi\u00f1a D.; Vilar S.; Uriarte E.; Borges F.; Ter\u00e1n C.; Synthesis and structure-activity relationship study of novel 3-heteroarylcoumarins based on pyridazine scaffold as selective MAO-B inhibitors. Eur J Med Chem  2017,139,1-11","journal-title":"Eur J Med Chem"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.ejmech.2013.02.009","volume":"63","author":"Matos M.J.","year":"2013","unstructured":"Matos M.J.; Vilar S.; Gonz\u00e1lez-Franco R.M.; Uriarte E.; Santana L.; Friedman C.; Tatonetti N.P.; Vi\u00f1a D.; Fontenla J.A.; Novel (coumarin-3-yl)carbamates as selective MAO-B inhibitors: Synthesis, in vitro and in vivo assays, theoretical evaluation of ADME properties and docking study. Eur J Med Chem  2013,63,151-161","journal-title":"Eur J Med Chem"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1002\/prot.10465","volume":"52","author":"Verdonk M.L.","year":"2003","unstructured":"Verdonk M.L.; Cole J.C.; Hartshorn M.J.; Murray C.W.; Taylor R.D.; Improved protein\u2013ligand docking using GOLD. Proteins  2003,52(4),609-623","journal-title":"Proteins"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"28182","DOI":"10.1021\/acsomega.1c04252","volume":"6","author":"Rehuman N.A.","year":"2021","unstructured":"Rehuman N.A.; Oh J.M.; Nath L.R.; Khames A.; Abdelgawad M.A.; Gambacorta N.; Nicolotti O.; Jat R.K.; Kim H.; Mathew B.; Halogenated coumarin-chalcones as multifunctional monoamine oxidase-B and butyrylcholinesterase inhibitors. ACS Omega  2021,6(42),28182-28193","journal-title":"ACS Omega"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.ejmech.2019.07.031","volume":"180","author":"Zhang C.","year":"2019","unstructured":"Zhang C.; Yang K.; Yu S.; Su J.; Yuan S.; Han J.; Chen Y.; Gu J.; Zhou T.; Bai R.; Xie Y.; Design, synthesis and biological evaluation of hydroxypyridinone-coumarin hybrids as multimodal monoamine oxidase B inhibitors and iron chelates against Alzheimer\u2019s disease. Eur J Med Chem  2019,180,367-382","journal-title":"Eur J Med Chem"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.ejmech.2016.03.014","volume":"115","author":"Xie Y.Y.","year":"2016","unstructured":"Xie Y.Y.; Lu Z.; Kong X.L.; Zhou T.; Bansal S.; Hider R.; Systematic comparison of the mono-, dimethyl- and trimethyl 3-hydroxy-4(1H)-pyridones \u2013 Attempted optimization of the orally active iron chelator, deferiprone. Eur J Med Chem  2016,115,132-140","journal-title":"Eur J Med Chem"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1021\/jm201475u","volume":"55","author":"Ma Y.","year":"2012","unstructured":"Ma Y.; Roy S.; Kong X.; Chen Y.; Liu D.; Hider R.C.; Design and synthesis of fluorinated iron chelators for metabolic study and brain uptake. J Med Chem  2012,55(5),2185-2195","journal-title":"J Med Chem"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"5848","DOI":"10.1021\/jm070677y","volume":"50","author":"Binda C.","year":"2007","unstructured":"Binda C.; Wang J.; Pisani L.; Caccia C.; Carotti A.; Salvati P.; Edmondson D.E.; Mattevi A.; Structures of human monoamine oxidase B complexes with selective noncovalent inhibitors: Safinamide and coumarin analogs. J Med Chem  2007,50(23),5848-5852","journal-title":"J Med Chem"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"33851","DOI":"10.1039\/C7RA04385F","volume":"7","author":"Chen Y.","year":"2017","unstructured":"Chen Y.; Lin H.; Zhu J.; Gu K.; Li Q.; He S.; Lu X.; Tan R.; Pei Y.; Wu L.; Bian Y.; Sun H.; Design, synthesis, in vitro and in vivo evaluation of tacrine\u2013cinnamic acid hybrids as multi-target acetyl- and butyrylcholinesterase inhibitors against Alzheimer\u2019s disease. RSC Advances  2017,7(54),33851-33867","journal-title":"RSC Advances"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"103986","DOI":"10.1016\/j.bioorg.2020.103986","volume":"101","author":"Rodr\u00edguez-Enr\u00edquez F.","year":"2020","unstructured":"Rodr\u00edguez-Enr\u00edquez F.; Vi\u00f1a D.; Uriarte E.; Fontenla J.A.; Matos M.J.; Discovery and optimization of 3-thiophenylcoumarins as novel agents against Parkinson\u2019s disease: Synthesis, in vitro and in vivo studies. Bioorg Chem  2020,101,103986","journal-title":"Bioorg Chem"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"4985","DOI":"10.1016\/j.bmcl.2013.06.050","volume":"23","author":"Robinson S.J.","year":"2013","unstructured":"Robinson S.J.; Petzer J.P.; Petzer A.; Bergh J.J.; Lourens A.C.; Selected furanochalcones as inhibitors of monoamine oxidase. Bioorg Med Chem Lett  2013,23(17),4985-4989","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1111\/j.1476-5381.2011.01426.x","volume":"164","author":"Duty S.","year":"2011","unstructured":"Duty S.; Jenner P.; Animal models of Parkinson\u2019s disease: A source of novel treatments and clues to the cause of the disease. Br J Pharmacol  2011,164(4),1357-1391","journal-title":"Br J Pharmacol"},{"key":"ref=76","author":"Maria FMB","year":"2012","unstructured":"Maria FMB; Alexandra M; Neves G; Nuno JDSPM; Francisco OC; Use of chromones, its derivatives, its pharmaceutically acceptable salts and its pro-drugs with the monoamine oxidase inhibiting activity and related therapeutic applications.  2012"},{"key":"ref=77","author":"Alexandra J","year":"2016","unstructured":"Alexandra J; Duncan GW; Ian N; Jinto JOSE; Chitralekha, R Labelled coumarin derivatives.   2016"},{"key":"ref=78","author":"Li L.","year":"2022","unstructured":"Li L.; Zhang D.; Bao X.; Gao F.;  Coumarin derivatives and application thereof in preventing and treating nervous system diseases.  2022"},{"key":"ref=79","author":"Liu G.","year":"2019","unstructured":"Liu G.; Chen N.; Sun M.; Hu J.; Song X.; Applications of coumarin derivatives in preventing and curing serious brain diseases.  2019"},{"key":"ref=80","author":"Liu G.","year":"2017","unstructured":"Liu G.; Chen N.; Sun M.; Hu J.; Song X.;  Preparation of coumarin derivative and application of coumarin derivative to control of serious cerebral disease.  2017"},{"key":"ref=81","author":"Sun B.","year":"2021","unstructured":"Sun B.; Synthesis method of C-3 alkyl substituted coumarin derivative.  2021"}],"container-title":["Mini-Reviews in Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0113895575290599240503080025","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/230134\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0113895575290599240503080025","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T11:04:37Z","timestamp":1730891077000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/230134\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":81,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0113895575290599240503080025","relation":{},"ISSN":["1389-5575"],"issn-type":[{"value":"1389-5575","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2023-12-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-03-14","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-03-18","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-08-19","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}